nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Ibuprofen—CXCL8—pancreatic cancer	0.00296	0.379	CrCbGaD
Esmolol—Ibuprofen—PPARG—pancreatic cancer	0.00204	0.262	CrCbGaD
Esmolol—Chlorphenesin—PTGS2—pancreatic cancer	0.00193	0.248	CrCbGaD
Esmolol—Myocardial infarction—Docetaxel—pancreatic cancer	0.00147	0.00166	CcSEcCtD
Esmolol—Decreased appetite—Sunitinib—pancreatic cancer	0.00146	0.00165	CcSEcCtD
Esmolol—Abnormal vision—Doxorubicin—pancreatic cancer	0.00146	0.00165	CcSEcCtD
Esmolol—Mental disability—Doxorubicin—pancreatic cancer	0.00145	0.00164	CcSEcCtD
Esmolol—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00145	0.00164	CcSEcCtD
Esmolol—Fatigue—Sunitinib—pancreatic cancer	0.00145	0.00164	CcSEcCtD
Esmolol—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.00145	0.00164	CcSEcCtD
Esmolol—Pain—Sunitinib—pancreatic cancer	0.00144	0.00162	CcSEcCtD
Esmolol—Constipation—Sunitinib—pancreatic cancer	0.00144	0.00162	CcSEcCtD
Esmolol—Asthenia—Tamoxifen—pancreatic cancer	0.00141	0.00159	CcSEcCtD
Esmolol—Convulsion—Fluorouracil—pancreatic cancer	0.00141	0.00159	CcSEcCtD
Esmolol—Chest pain—Gemcitabine—pancreatic cancer	0.0014	0.00159	CcSEcCtD
Esmolol—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.0014	0.00159	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.0014	0.00158	CcSEcCtD
Esmolol—Confusional state—Irinotecan—pancreatic cancer	0.00139	0.00158	CcSEcCtD
Esmolol—Asthenia—Erlotinib—pancreatic cancer	0.00139	0.00157	CcSEcCtD
Esmolol—Pruritus—Tamoxifen—pancreatic cancer	0.00139	0.00157	CcSEcCtD
Esmolol—Oedema—Irinotecan—pancreatic cancer	0.00138	0.00157	CcSEcCtD
Esmolol—Chest pain—Fluorouracil—pancreatic cancer	0.00138	0.00156	CcSEcCtD
Esmolol—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00137	0.00155	CcSEcCtD
Esmolol—Pruritus—Erlotinib—pancreatic cancer	0.00137	0.00155	CcSEcCtD
Esmolol—Shock—Irinotecan—pancreatic cancer	0.00136	0.00154	CcSEcCtD
Esmolol—Nervous system disorder—Irinotecan—pancreatic cancer	0.00136	0.00153	CcSEcCtD
Esmolol—Rhinitis—Docetaxel—pancreatic cancer	0.00135	0.00153	CcSEcCtD
Esmolol—Oedema—Gemcitabine—pancreatic cancer	0.00135	0.00152	CcSEcCtD
Esmolol—Cardiac failure—Epirubicin—pancreatic cancer	0.00134	0.00152	CcSEcCtD
Esmolol—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.00134	0.00151	CcSEcCtD
Esmolol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00134	0.00151	CcSEcCtD
Esmolol—Confusional state—Fluorouracil—pancreatic cancer	0.00133	0.00151	CcSEcCtD
Esmolol—Pharyngitis—Docetaxel—pancreatic cancer	0.00133	0.00151	CcSEcCtD
Esmolol—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00133	0.0015	CcSEcCtD
Esmolol—Body temperature increased—Sunitinib—pancreatic cancer	0.00133	0.0015	CcSEcCtD
Esmolol—Oedema—Fluorouracil—pancreatic cancer	0.00132	0.0015	CcSEcCtD
Esmolol—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00132	0.0015	CcSEcCtD
Esmolol—Urethral disorder—Docetaxel—pancreatic cancer	0.00132	0.00149	CcSEcCtD
Esmolol—Anorexia—Irinotecan—pancreatic cancer	0.00132	0.00149	CcSEcCtD
Esmolol—Skin disorder—Gemcitabine—pancreatic cancer	0.00131	0.00148	CcSEcCtD
Esmolol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.0013	0.00147	CcSEcCtD
Esmolol—Nervous system disorder—Fluorouracil—pancreatic cancer	0.0013	0.00147	CcSEcCtD
Esmolol—Visual impairment—Docetaxel—pancreatic cancer	0.0013	0.00147	CcSEcCtD
Esmolol—Dizziness—Tamoxifen—pancreatic cancer	0.0013	0.00147	CcSEcCtD
Esmolol—Hypotension—Irinotecan—pancreatic cancer	0.00129	0.00146	CcSEcCtD
Esmolol—Anorexia—Gemcitabine—pancreatic cancer	0.00128	0.00145	CcSEcCtD
Esmolol—Dizziness—Erlotinib—pancreatic cancer	0.00128	0.00145	CcSEcCtD
Esmolol—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00127	0.00144	CcSEcCtD
Esmolol—Anorexia—Fluorouracil—pancreatic cancer	0.00126	0.00143	CcSEcCtD
Esmolol—Hypotension—Gemcitabine—pancreatic cancer	0.00126	0.00142	CcSEcCtD
Esmolol—Flushing—Docetaxel—pancreatic cancer	0.00125	0.00141	CcSEcCtD
Esmolol—Cardiac disorder—Docetaxel—pancreatic cancer	0.00125	0.00141	CcSEcCtD
Esmolol—Cardiac arrest—Epirubicin—pancreatic cancer	0.00125	0.00141	CcSEcCtD
Esmolol—Vomiting—Tamoxifen—pancreatic cancer	0.00125	0.00141	CcSEcCtD
Esmolol—Cardiac failure—Doxorubicin—pancreatic cancer	0.00124	0.00141	CcSEcCtD
Esmolol—Paraesthesia—Irinotecan—pancreatic cancer	0.00124	0.00141	CcSEcCtD
Esmolol—Hypotension—Fluorouracil—pancreatic cancer	0.00124	0.0014	CcSEcCtD
Esmolol—Vomiting—Erlotinib—pancreatic cancer	0.00123	0.0014	CcSEcCtD
Esmolol—Dyspnoea—Irinotecan—pancreatic cancer	0.00123	0.0014	CcSEcCtD
Esmolol—Somnolence—Irinotecan—pancreatic cancer	0.00123	0.00139	CcSEcCtD
Esmolol—Headache—Tamoxifen—pancreatic cancer	0.00123	0.00139	CcSEcCtD
Esmolol—Angiopathy—Docetaxel—pancreatic cancer	0.00122	0.00138	CcSEcCtD
Esmolol—Dyspepsia—Irinotecan—pancreatic cancer	0.00122	0.00138	CcSEcCtD
Esmolol—Headache—Erlotinib—pancreatic cancer	0.00121	0.00137	CcSEcCtD
Esmolol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00121	0.00137	CcSEcCtD
Esmolol—Chills—Docetaxel—pancreatic cancer	0.00121	0.00137	CcSEcCtD
Esmolol—Asthenia—Sunitinib—pancreatic cancer	0.0012	0.00136	CcSEcCtD
Esmolol—Decreased appetite—Irinotecan—pancreatic cancer	0.0012	0.00136	CcSEcCtD
Esmolol—Dyspnoea—Gemcitabine—pancreatic cancer	0.0012	0.00136	CcSEcCtD
Esmolol—Somnolence—Gemcitabine—pancreatic cancer	0.0012	0.00136	CcSEcCtD
Esmolol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00119	0.00135	CcSEcCtD
Esmolol—Fatigue—Irinotecan—pancreatic cancer	0.00119	0.00135	CcSEcCtD
Esmolol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00119	0.00135	CcSEcCtD
Esmolol—Pruritus—Sunitinib—pancreatic cancer	0.00119	0.00134	CcSEcCtD
Esmolol—Pain—Irinotecan—pancreatic cancer	0.00118	0.00134	CcSEcCtD
Esmolol—Constipation—Irinotecan—pancreatic cancer	0.00118	0.00134	CcSEcCtD
Esmolol—Dyspnoea—Fluorouracil—pancreatic cancer	0.00118	0.00134	CcSEcCtD
Esmolol—Mental disorder—Docetaxel—pancreatic cancer	0.00118	0.00133	CcSEcCtD
Esmolol—Somnolence—Fluorouracil—pancreatic cancer	0.00118	0.00133	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00117	0.00133	CcSEcCtD
Esmolol—Erythema—Docetaxel—pancreatic cancer	0.00117	0.00133	CcSEcCtD
Esmolol—Decreased appetite—Gemcitabine—pancreatic cancer	0.00117	0.00133	CcSEcCtD
Esmolol—Dyspepsia—Fluorouracil—pancreatic cancer	0.00117	0.00132	CcSEcCtD
Esmolol—Nausea—Tamoxifen—pancreatic cancer	0.00116	0.00132	CcSEcCtD
Esmolol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00116	0.00132	CcSEcCtD
Esmolol—Fatigue—Gemcitabine—pancreatic cancer	0.00116	0.00131	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00115	0.00131	CcSEcCtD
Esmolol—Constipation—Gemcitabine—pancreatic cancer	0.00115	0.0013	CcSEcCtD
Esmolol—Pain—Gemcitabine—pancreatic cancer	0.00115	0.0013	CcSEcCtD
Esmolol—Nausea—Erlotinib—pancreatic cancer	0.00115	0.0013	CcSEcCtD
Esmolol—Decreased appetite—Fluorouracil—pancreatic cancer	0.00115	0.0013	CcSEcCtD
Esmolol—Dysgeusia—Docetaxel—pancreatic cancer	0.00115	0.0013	CcSEcCtD
Esmolol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00114	0.00129	CcSEcCtD
Esmolol—Feeling abnormal—Irinotecan—pancreatic cancer	0.00114	0.00129	CcSEcCtD
Esmolol—Pain—Fluorouracil—pancreatic cancer	0.00113	0.00128	CcSEcCtD
Esmolol—Dizziness—Sunitinib—pancreatic cancer	0.00111	0.00126	CcSEcCtD
Esmolol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00111	0.00126	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—pancreatic cancer	0.0011	0.00125	CcSEcCtD
Esmolol—Body temperature increased—Irinotecan—pancreatic cancer	0.00109	0.00124	CcSEcCtD
Esmolol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00109	0.00124	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00109	0.00123	CcSEcCtD
Esmolol—Vomiting—Sunitinib—pancreatic cancer	0.00107	0.00121	CcSEcCtD
Esmolol—Body temperature increased—Gemcitabine—pancreatic cancer	0.00106	0.00121	CcSEcCtD
Esmolol—Dysuria—Epirubicin—pancreatic cancer	0.00106	0.0012	CcSEcCtD
Esmolol—Urticaria—Fluorouracil—pancreatic cancer	0.00105	0.00119	CcSEcCtD
Esmolol—Headache—Sunitinib—pancreatic cancer	0.00105	0.00119	CcSEcCtD
Esmolol—Syncope—Docetaxel—pancreatic cancer	0.00105	0.00119	CcSEcCtD
Esmolol—Body temperature increased—Fluorouracil—pancreatic cancer	0.00105	0.00118	CcSEcCtD
Esmolol—Loss of consciousness—Docetaxel—pancreatic cancer	0.00103	0.00117	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—pancreatic cancer	0.00102	0.00116	CcSEcCtD
Esmolol—Convulsion—Docetaxel—pancreatic cancer	0.00101	0.00115	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—pancreatic cancer	0.00101	0.00114	CcSEcCtD
Esmolol—Chest pain—Docetaxel—pancreatic cancer	0.000997	0.00113	CcSEcCtD
Esmolol—Nausea—Sunitinib—pancreatic cancer	0.000997	0.00113	CcSEcCtD
Esmolol—Asthenia—Irinotecan—pancreatic cancer	0.000992	0.00112	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000991	0.00112	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00099	0.00112	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—pancreatic cancer	0.000981	0.00111	CcSEcCtD
Esmolol—Dry mouth—Docetaxel—pancreatic cancer	0.000975	0.0011	CcSEcCtD
Esmolol—Asthenia—Gemcitabine—pancreatic cancer	0.000966	0.00109	CcSEcCtD
Esmolol—Confusional state—Docetaxel—pancreatic cancer	0.000964	0.00109	CcSEcCtD
Esmolol—Oedema—Docetaxel—pancreatic cancer	0.000956	0.00108	CcSEcCtD
Esmolol—Pruritus—Gemcitabine—pancreatic cancer	0.000953	0.00108	CcSEcCtD
Esmolol—Shock—Docetaxel—pancreatic cancer	0.00094	0.00106	CcSEcCtD
Esmolol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000937	0.00106	CcSEcCtD
Esmolol—Pruritus—Fluorouracil—pancreatic cancer	0.000937	0.00106	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—pancreatic cancer	0.000935	0.00106	CcSEcCtD
Esmolol—Skin disorder—Docetaxel—pancreatic cancer	0.000928	0.00105	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—pancreatic cancer	0.000924	0.00105	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000917	0.00104	CcSEcCtD
Esmolol—Dizziness—Irinotecan—pancreatic cancer	0.000914	0.00103	CcSEcCtD
Esmolol—Anorexia—Docetaxel—pancreatic cancer	0.000911	0.00103	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—pancreatic cancer	0.00091	0.00103	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—pancreatic cancer	0.0009	0.00102	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000896	0.00101	CcSEcCtD
Esmolol—Hypotension—Docetaxel—pancreatic cancer	0.000893	0.00101	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—pancreatic cancer	0.000889	0.00101	CcSEcCtD
Esmolol—Vomiting—Irinotecan—pancreatic cancer	0.000879	0.000995	CcSEcCtD
Esmolol—Dizziness—Fluorouracil—pancreatic cancer	0.000876	0.000991	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—pancreatic cancer	0.000874	0.00099	CcSEcCtD
Esmolol—Headache—Irinotecan—pancreatic cancer	0.000866	0.00098	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—pancreatic cancer	0.000863	0.111	CrCbGaD
Esmolol—Paraesthesia—Docetaxel—pancreatic cancer	0.000858	0.000971	CcSEcCtD
Esmolol—Vomiting—Gemcitabine—pancreatic cancer	0.000856	0.000969	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—pancreatic cancer	0.000855	0.000968	CcSEcCtD
Esmolol—Dyspnoea—Docetaxel—pancreatic cancer	0.000852	0.000965	CcSEcCtD
Esmolol—Somnolence—Docetaxel—pancreatic cancer	0.00085	0.000962	CcSEcCtD
Esmolol—Headache—Gemcitabine—pancreatic cancer	0.000844	0.000955	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—pancreatic cancer	0.000842	0.000953	CcSEcCtD
Esmolol—Flushing—Epirubicin—pancreatic cancer	0.000842	0.000953	CcSEcCtD
Esmolol—Vomiting—Fluorouracil—pancreatic cancer	0.000842	0.000953	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—pancreatic cancer	0.000842	0.000953	CcSEcCtD
Esmolol—Dyspepsia—Docetaxel—pancreatic cancer	0.000841	0.000952	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—pancreatic cancer	0.000833	0.000943	CcSEcCtD
Esmolol—Decreased appetite—Docetaxel—pancreatic cancer	0.000831	0.00094	CcSEcCtD
Esmolol—Headache—Fluorouracil—pancreatic cancer	0.000829	0.000939	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000829	0.000939	CcSEcCtD
Esmolol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000825	0.000934	CcSEcCtD
Esmolol—Fatigue—Docetaxel—pancreatic cancer	0.000824	0.000933	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—pancreatic cancer	0.000823	0.000932	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—pancreatic cancer	0.000823	0.000932	CcSEcCtD
Esmolol—Nausea—Irinotecan—pancreatic cancer	0.000821	0.00093	CcSEcCtD
Esmolol—Pain—Docetaxel—pancreatic cancer	0.000817	0.000925	CcSEcCtD
Esmolol—Constipation—Docetaxel—pancreatic cancer	0.000817	0.000925	CcSEcCtD
Esmolol—Chills—Epirubicin—pancreatic cancer	0.000814	0.000922	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—pancreatic cancer	0.000809	0.000916	CcSEcCtD
Esmolol—Nausea—Gemcitabine—pancreatic cancer	0.0008	0.000906	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—pancreatic cancer	0.000795	0.0009	CcSEcCtD
Esmolol—Erythema—Epirubicin—pancreatic cancer	0.00079	0.000894	CcSEcCtD
Esmolol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000787	0.000892	CcSEcCtD
Esmolol—Nausea—Fluorouracil—pancreatic cancer	0.000786	0.00089	CcSEcCtD
Esmolol—Flushing—Doxorubicin—pancreatic cancer	0.000779	0.000882	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000779	0.000882	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—pancreatic cancer	0.000773	0.000876	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—pancreatic cancer	0.000762	0.000862	CcSEcCtD
Esmolol—Body temperature increased—Docetaxel—pancreatic cancer	0.000755	0.000855	CcSEcCtD
Esmolol—Chills—Doxorubicin—pancreatic cancer	0.000753	0.000853	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—pancreatic cancer	0.000735	0.000833	CcSEcCtD
Esmolol—Erythema—Doxorubicin—pancreatic cancer	0.000731	0.000827	CcSEcCtD
Esmolol—Agitation—Epirubicin—pancreatic cancer	0.000726	0.000822	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—pancreatic cancer	0.000716	0.00081	CcSEcCtD
Esmolol—Syncope—Epirubicin—pancreatic cancer	0.000708	0.000802	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000694	0.000786	CcSEcCtD
Esmolol—Asthenia—Docetaxel—pancreatic cancer	0.000686	0.000776	CcSEcCtD
Esmolol—Convulsion—Epirubicin—pancreatic cancer	0.000684	0.000775	CcSEcCtD
Esmolol—Pruritus—Docetaxel—pancreatic cancer	0.000676	0.000765	CcSEcCtD
Esmolol—Chest pain—Epirubicin—pancreatic cancer	0.000672	0.000761	CcSEcCtD
Esmolol—Agitation—Doxorubicin—pancreatic cancer	0.000672	0.00076	CcSEcCtD
Esmolol—Anxiety—Epirubicin—pancreatic cancer	0.00067	0.000759	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000668	0.000756	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—pancreatic cancer	0.000658	0.000744	CcSEcCtD
Esmolol—Syncope—Doxorubicin—pancreatic cancer	0.000655	0.000742	CcSEcCtD
Esmolol—Confusional state—Epirubicin—pancreatic cancer	0.00065	0.000736	CcSEcCtD
Esmolol—Oedema—Epirubicin—pancreatic cancer	0.000645	0.00073	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000642	0.000727	CcSEcCtD
Esmolol—Shock—Epirubicin—pancreatic cancer	0.000634	0.000718	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—pancreatic cancer	0.000633	0.000717	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—pancreatic cancer	0.000632	0.000716	CcSEcCtD
Esmolol—Dizziness—Docetaxel—pancreatic cancer	0.000632	0.000715	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—pancreatic cancer	0.000626	0.000709	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000623	0.000705	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—pancreatic cancer	0.000622	0.000704	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—pancreatic cancer	0.00062	0.000702	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000618	0.000699	CcSEcCtD
Esmolol—Anorexia—Epirubicin—pancreatic cancer	0.000614	0.000696	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—pancreatic cancer	0.000608	0.000689	CcSEcCtD
Esmolol—Vomiting—Docetaxel—pancreatic cancer	0.000608	0.000688	CcSEcCtD
Esmolol—Hypotension—Epirubicin—pancreatic cancer	0.000602	0.000682	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—pancreatic cancer	0.000601	0.000681	CcSEcCtD
Esmolol—Headache—Docetaxel—pancreatic cancer	0.000599	0.000678	CcSEcCtD
Esmolol—Oedema—Doxorubicin—pancreatic cancer	0.000596	0.000675	CcSEcCtD
Esmolol—Shock—Doxorubicin—pancreatic cancer	0.000587	0.000664	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000585	0.000662	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—pancreatic cancer	0.000579	0.000656	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—pancreatic cancer	0.000579	0.000655	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000577	0.000653	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—pancreatic cancer	0.000575	0.000651	CcSEcCtD
Esmolol—Somnolence—Epirubicin—pancreatic cancer	0.000573	0.000649	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—pancreatic cancer	0.000568	0.000644	CcSEcCtD
Esmolol—Nausea—Docetaxel—pancreatic cancer	0.000568	0.000643	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—pancreatic cancer	0.000567	0.000642	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—pancreatic cancer	0.00056	0.000634	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—pancreatic cancer	0.000557	0.000631	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000556	0.00063	CcSEcCtD
Esmolol—Fatigue—Epirubicin—pancreatic cancer	0.000556	0.000629	CcSEcCtD
Esmolol—Pain—Epirubicin—pancreatic cancer	0.000551	0.000624	CcSEcCtD
Esmolol—Constipation—Epirubicin—pancreatic cancer	0.000551	0.000624	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000536	0.000606	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000532	0.000602	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000531	0.000601	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—pancreatic cancer	0.00053	0.0006	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000525	0.000594	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000518	0.000587	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000515	0.000583	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—pancreatic cancer	0.000514	0.000582	CcSEcCtD
Esmolol—Urticaria—Epirubicin—pancreatic cancer	0.000512	0.00058	CcSEcCtD
Esmolol—Constipation—Doxorubicin—pancreatic cancer	0.00051	0.000577	CcSEcCtD
Esmolol—Pain—Doxorubicin—pancreatic cancer	0.00051	0.000577	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—pancreatic cancer	0.00051	0.000577	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000491	0.000556	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—pancreatic cancer	0.000474	0.000536	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000471	0.000534	CcSEcCtD
Esmolol—Asthenia—Epirubicin—pancreatic cancer	0.000462	0.000524	CcSEcCtD
Esmolol—Pruritus—Epirubicin—pancreatic cancer	0.000456	0.000516	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—pancreatic cancer	0.000428	0.000484	CcSEcCtD
Esmolol—Dizziness—Epirubicin—pancreatic cancer	0.000426	0.000483	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—pancreatic cancer	0.000422	0.000478	CcSEcCtD
Esmolol—Vomiting—Epirubicin—pancreatic cancer	0.00041	0.000464	CcSEcCtD
Esmolol—Headache—Epirubicin—pancreatic cancer	0.000404	0.000457	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—pancreatic cancer	0.000394	0.000446	CcSEcCtD
Esmolol—Nausea—Epirubicin—pancreatic cancer	0.000383	0.000433	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—pancreatic cancer	0.000379	0.000429	CcSEcCtD
Esmolol—Headache—Doxorubicin—pancreatic cancer	0.000374	0.000423	CcSEcCtD
Esmolol—ADRB1—Signaling Pathways—GDI2—pancreatic cancer	0.000356	0.00327	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000356	0.00327	CbGpPWpGaD
Esmolol—Nausea—Doxorubicin—pancreatic cancer	0.000354	0.000401	CcSEcCtD
Esmolol—ADRB1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000349	0.0032	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GDI1—pancreatic cancer	0.000348	0.0032	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GDI2—pancreatic cancer	0.000348	0.0032	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PPY—pancreatic cancer	0.000342	0.00314	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000341	0.00313	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—SST—pancreatic cancer	0.000338	0.0031	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000336	0.00308	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PPY—pancreatic cancer	0.000334	0.00307	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—SST—pancreatic cancer	0.000331	0.00304	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—SSTR3—pancreatic cancer	0.00033	0.00303	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000328	0.00301	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000324	0.00298	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—SSTR3—pancreatic cancer	0.000323	0.00297	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000317	0.00291	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000317	0.00291	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CNR1—pancreatic cancer	0.000312	0.00286	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PPY—pancreatic cancer	0.00031	0.00285	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—SSTR1—pancreatic cancer	0.00031	0.00284	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CNR1—pancreatic cancer	0.000305	0.0028	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000305	0.0028	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PPY—pancreatic cancer	0.000304	0.00279	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—GCG—pancreatic cancer	0.000301	0.00277	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—SSTR2—pancreatic cancer	0.000298	0.00274	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—GCG—pancreatic cancer	0.000295	0.00271	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000294	0.0027	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCKBR—pancreatic cancer	0.000288	0.00264	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000287	0.00264	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—AGTR1—pancreatic cancer	0.000281	0.00258	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GAST—pancreatic cancer	0.000279	0.00256	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GAST—pancreatic cancer	0.000273	0.0025	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—SCT—pancreatic cancer	0.000264	0.00243	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—SCT—pancreatic cancer	0.000258	0.00237	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GAST—pancreatic cancer	0.000253	0.00232	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CCK—pancreatic cancer	0.000252	0.00231	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GAST—pancreatic cancer	0.000248	0.00227	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CCK—pancreatic cancer	0.000247	0.00226	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000246	0.00225	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000246	0.00225	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000242	0.00222	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00024	0.00221	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CNR2—pancreatic cancer	0.00024	0.00221	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—SCT—pancreatic cancer	0.00024	0.0022	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000236	0.00217	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—SCT—pancreatic cancer	0.000235	0.00215	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRLHR—pancreatic cancer	0.000229	0.00211	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCK—pancreatic cancer	0.000229	0.0021	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRLHR—pancreatic cancer	0.000224	0.00206	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCK—pancreatic cancer	0.000224	0.00206	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CNR2—pancreatic cancer	0.000223	0.00205	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000223	0.00205	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000219	0.00201	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CNR2—pancreatic cancer	0.000218	0.002	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000218	0.002	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000218	0.002	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000216	0.00198	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000216	0.00198	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000215	0.00197	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000213	0.00195	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000211	0.00194	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000211	0.00194	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000209	0.00192	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000204	0.00188	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—SHH—pancreatic cancer	0.0002	0.00184	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IAPP—pancreatic cancer	0.000198	0.00181	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—SHH—pancreatic cancer	0.000196	0.0018	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—DTX1—pancreatic cancer	0.000195	0.00179	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SSTR3—pancreatic cancer	0.000195	0.00179	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IAPP—pancreatic cancer	0.000193	0.00177	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—SST—pancreatic cancer	0.000191	0.00175	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—DTX1—pancreatic cancer	0.000191	0.00175	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SSTR3—pancreatic cancer	0.000191	0.00175	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PTHLH—pancreatic cancer	0.00019	0.00174	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PTCH1—pancreatic cancer	0.00019	0.00174	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	0.000187	0.00172	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	0.000187	0.00172	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000186	0.0017	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000186	0.0017	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	0.000183	0.00168	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.000183	0.00168	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	0.00018	0.00165	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	0.000179	0.00165	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000176	0.00162	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	0.000176	0.00162	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	0.000174	0.0016	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	0.000173	0.00159	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000173	0.00159	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000172	0.00158	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	0.00017	0.00156	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	0.00017	0.00156	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	0.00017	0.00156	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000169	0.00155	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	0.000167	0.00153	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	0.000163	0.0015	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	0.000163	0.0015	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000162	0.00149	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	0.00016	0.00147	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	0.00016	0.00147	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	0.00016	0.00147	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000159	0.00146	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	0.000159	0.00146	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000159	0.00146	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.000157	0.00144	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000156	0.00143	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000156	0.00143	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	0.000155	0.00142	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	0.000153	0.00141	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000151	0.00139	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	0.00015	0.00137	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	0.000149	0.00137	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000147	0.00135	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	0.000146	0.00134	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000144	0.00132	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	0.000142	0.0013	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	0.000142	0.0013	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	0.000139	0.00127	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000139	0.00127	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	0.000135	0.00124	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	0.000132	0.00121	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	0.000132	0.00121	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	0.000132	0.00121	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000132	0.00121	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	0.00013	0.00119	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	0.000129	0.00118	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.000129	0.00118	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000129	0.00118	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000127	0.00116	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	0.000126	0.00115	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	0.000124	0.00114	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	0.000123	0.00113	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	0.000121	0.00111	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	0.000118	0.00108	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000117	0.00108	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	0.000117	0.00107	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	0.000116	0.00106	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000115	0.00105	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	0.000114	0.00105	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	0.000112	0.00103	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	0.000112	0.00103	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	0.00011	0.00101	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	0.00011	0.00101	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SST—pancreatic cancer	0.000102	0.000941	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000101	0.000928	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	0.0001	0.000921	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SST—pancreatic cancer	0.0001	0.00092	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	9.99e-05	0.000917	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	9.89e-05	0.000908	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	9.81e-05	0.000901	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	9.77e-05	0.000897	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	9.46e-05	0.000868	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	9.25e-05	0.000849	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	9.18e-05	0.000843	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	9.13e-05	0.000838	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	8.98e-05	0.000824	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	8.93e-05	0.00082	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.88e-05	0.000816	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	8.71e-05	0.0008	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.69e-05	0.000798	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	8.59e-05	0.000788	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	8.52e-05	0.000782	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	8.4e-05	0.000771	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	8.07e-05	0.000741	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	7.89e-05	0.000725	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.74e-05	0.000711	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.57e-05	0.000695	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	7.52e-05	0.00069	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.44e-05	0.000683	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	7.36e-05	0.000675	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	7.34e-05	0.000674	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	7.28e-05	0.000668	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	7.18e-05	0.000659	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.03e-05	0.000646	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	6.88e-05	0.000632	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	6.76e-05	0.00062	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	6.61e-05	0.000607	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	6.43e-05	0.000591	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	6.29e-05	0.000578	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	6.15e-05	0.000565	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	6.14e-05	0.000564	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	6.02e-05	0.000553	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	6.01e-05	0.000552	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	6e-05	0.000551	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	5.88e-05	0.00054	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	5.88e-05	0.000539	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	5.76e-05	0.000529	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	5.6e-05	0.000514	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	5.54e-05	0.000509	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	5.48e-05	0.000503	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	5.42e-05	0.000498	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	5.42e-05	0.000498	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	5.42e-05	0.000498	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	5.36e-05	0.000492	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	5.3e-05	0.000487	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	5.3e-05	0.000487	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	5.24e-05	0.000481	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	4.94e-05	0.000453	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	4.83e-05	0.000444	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	4.77e-05	0.000438	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.72e-05	0.000433	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	4.67e-05	0.000428	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	4.66e-05	0.000428	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.62e-05	0.000424	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	4.56e-05	0.000419	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.29e-05	0.000394	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.19e-05	0.000385	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	4.15e-05	0.000381	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	4.06e-05	0.000373	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	3.99e-05	0.000366	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	3.97e-05	0.000364	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	3.9e-05	0.000359	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	3.88e-05	0.000356	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	3.86e-05	0.000354	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	3.82e-05	0.000351	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	3.77e-05	0.000346	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	3.74e-05	0.000343	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	3.72e-05	0.000341	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	3.68e-05	0.000338	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	3.64e-05	0.000334	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	3.61e-05	0.000331	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	3.6e-05	0.000331	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	3.59e-05	0.00033	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	3.53e-05	0.000324	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	3.51e-05	0.000322	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	3.5e-05	0.000322	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	3.43e-05	0.000315	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	3.33e-05	0.000306	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	3.26e-05	0.000299	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	3.24e-05	0.000298	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	3.21e-05	0.000295	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	3.2e-05	0.000294	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	3.17e-05	0.000291	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	3.14e-05	0.000288	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	3.13e-05	0.000288	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	2.98e-05	0.000274	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	2.98e-05	0.000273	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	2.92e-05	0.000268	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	2.92e-05	0.000268	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	2.91e-05	0.000267	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	2.85e-05	0.000262	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	2.76e-05	0.000253	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	2.7e-05	0.000248	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	2.53e-05	0.000232	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	2.48e-05	0.000227	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	2.45e-05	0.000225	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	2.4e-05	0.00022	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.34e-05	0.000215	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	2.29e-05	0.00021	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	2.07e-05	0.00019	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	2.02e-05	0.000186	CbGpPWpGaD
